Search clinical trials for: [18F]MNI-958

Total 9013 results

National Cancer Institute (NCI)

Enrolling by invitation

18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer

Prostatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Prostate Neoplasms | Prostatic Cancer

United States
RenJi Hospital

Unknown

Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCC

Esophageal Squamous Cell Carcinoma

China
Centre Antoine Lacassagne

Recruiting

18F-FDG PET Scan and MRI Diffusion.Evaluation of the Early Therapeutic Response of Diffuse Large B-cell Lymphoma (LYMPHODTECT)

Diffuse Large B Cell Lymphoma

France
Institut de cancérologie Strasbourg Europe
ICube Laboratory

Completed

Creation of a Probabilistic Atlas of Normal Cerebral Uptake of 18F-FDG in PET/MRI. (ATLATEP)

Brain Diseases

France
Washington University School of Medicine

Recruiting

Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease

Alzheimer Disease

United States
Brigham and Women's Hospital

Recruiting

Longitudinal Tracking of Patients Diagnosed With Neurodegenerative Movement Disorders

Synucleinopathies | Neurodegenerative Diseases | Ataxia | sca3 | MSA - Multiple System Atrophy

United States
St. Jude Children's Research Hospital

Recruiting

Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study

Brain Tumor | Medulloblastoma

United States
Peter MacCallum Cancer Centre, Australia

Recruiting

Hepatocellular Carcinoma Imaging Using PSMA PET/CT (HepaSMART)

Hepatocellular Carcinoma

Australia
First Affiliated Hospital of Fujian Medical University

Recruiting

Tau PET Imaging With 18F-T807(AV1451) in Neurodegenerative Disorders

Neurodegenerative Disorders

China
National Cancer Institute (NCI)

Recruiting

Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

Prostate Cancer

United States
Northwestern University
Progenics Pharmaceuticals, Inc.

Recruiting

PET/MRI for the Staging of Newly Diagnosed Prostate Cancer

Prostate Cancer

United States
University Health Network, Toronto

Active, not recruiting

PSMA PET Registry (18F-DCFPyL) (PM-PPR)

Carcinoma of Prostate

Canada
National Institute on Alcohol Abuse and Alcoholism...

Completed

Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People

Normal Physiology

United States
Ashok Muthukrishnan
Progenics Pharmaceuticals, Inc.

Terminated

18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer

Prostate Cancer

United States
National Institute of Mental Health (NIMH)

Completed

[18F]SF12051 for Imaging the 18-kDa Translocator Protein (TSPO) in Brain and Whole Body of Healthy Subjects

Healthy

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer

Breast Cancer

United States
University Hospital, Ghent

Completed

PSMA-PET/CT for Prostate Cancer (NGP1)

Prostate Cancer

Belgium
Harbin Medical University

Completed

EGFR Molecular Classification In Vivo

Molecular Imaging

China
Sidney Kimmel Comprehensive Cancer Center at Johns...
Prostate Cancer Foundation; Radiological Society of North America

Completed

Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate Cancer

Prostate Cancer

United States
University Hospital, Bordeaux

Terminated

Molecular Imaging of Inflammation With 18F-PBR06 to Identify Unstable Carotid Plaques in Patients With Stroke (PLAQINSTEP)

Stroke

France
Oriental Neurosurgery Evidence-Based-Study Team

Unknown

18F-S16 PET/CT in Healthy Volunteers and Patients With Neurodegenerative Dementia

Neurodegenerative Dementia

China
Navidea Biopharmaceuticals

Unknown

Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI) (NAV4-04)

Mild Cognitive Impairment

United States
Navidea Biopharmaceuticals

Unknown

Efficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's Disease

Alzheimer Disease

United States
GlaxoSmithKline

Terminated

[18F]PBR111 and Microglial Activation in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Institute for Neurodegenerative Disorders

Completed

Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions (PBR111)

Alzheimer Disease

United States
Universitaire Ziekenhuizen KU Leuven

Unknown

Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients

Adenocarcinoma | Rectal Neoplasms

Belgium
Guy's and St Thomas' NHS Foundation Trust
King's College London

Not yet recruiting

Assessing Cancer Treatment Response to Therapy Using 18F-FSPG PET

Cancer | Diagnosis | Resistant Cancer | Response, Acute Phase
University College, London
Imperial College London; Cancer Research UK; National Cancer Imaging Translational...

Recruiting

[18F]FPIA PET/CT Imaging in Patients With Solid Tumours ([18F]FPIA)

Cancer | Tumor, Solid

United Kingdom
The First Affiliated Hospital of Guangzhou Medical...

Unknown

The 18F Peel-way Sheath Versus the 18F Access Sheath With a Suction-evacuation Function MPCNL for the Management of 2-5cm Size Kidney Stones

Renal Calculi

China
Stephen Y. Chan
National Heart, Lung, and Blood Institute (NHLBI); Bayer

Recruiting

PET Image in PAH Patients

Pulmonary Arterial Hypertension

United States
Avid Radiopharmaceuticals

Completed

A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)

Parkinson's Disease | Alzheimer's Disease | Dementia With Lewy Bodies

United States
Dana-Farber Cancer Institute
National Comprehensive Cancer Network; AVEO Pharmaceuticals, Inc.

Terminated

Tivozanib As Maintenance Therapy In GYN

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma

United States
AbbVie (prior sponsor, Abbott)
Massachusetts General Hospital

Completed

The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4 (PRIMO)

Chronic Kidney Disease | Left Ventricular Hypertrophy

United States, Australia, Czech Republic, Germany, Italy, Poland, Puerto Rico, Romania, Russian Federation, Spain, Taiwan, United Kingdom
University of Edinburgh

Completed

Assessment of Risk in Thoracic Aortopathy Using 18F-Sodium Fluoride (AoRTAS)

Bicuspid Aortic Valve | Aortic Dissection | Thoracic Aortic Aneurysm

United Kingdom
Peking Union Medical College Hospital

Unknown

18F-FDG PET/CT for IgG4-Related Disease

Autoimmune Disease

China
National Cancer Institute (NCI)

Completed

17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease

Kidney Cancer | Hippel-Lindau Disease

United States
Cook Children's Health Care System

Recruiting

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Insulinoma | Congenital Hyperinsulinism

United States
University of Arkansas

Withdrawn

Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor Therapy

Squamous Cell Carcinoma of the Head and Neck

United States
Marcelo F. Di Carli, MD, FACC

Completed

FET-PET for Evaluation of Response of Recurrent GBM to Avastin

Glioblastoma Multiforme | GBM

United States
Nektar Therapeutics
Eli Lilly and Company

Completed

A Study of LY3471851 in Participants With Eczema

Dermatitis, Atopic

United States
Warner Chilcott

Terminated

Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction

Erectile Dysfunction

United States
Huashan Hospital

Recruiting

CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging

Neurodegenerative Diseases | Alzheimer Disease | Positron Emission Tomography

China
HTA Co., Ltd.

Recruiting

Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer

Prostate Cancer

China
Jilin University

Recruiting

18F-FAPI PET/CT in Patients With Various Types of Cancer

Cancer

China
Children's Hospital of Philadelphia
Blue Earth Diagnostics; Dragon Master Foundation

Not yet recruiting

Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG

Glioma | Low-grade Glioma | Glioma, Malignant | Low Grade Glioma of Brain | Glioma Intracranial

United States
Invicro

Recruiting

Plasma P-tau2017 and Quantitative Amyloid PET Imaging

Alzheimer Disease

United States
Invicro

Recruiting

Evaluation of [18F]APN-1607 as a PET Biomarker

Healthy Volunteers | Progressive Supranuclear Palsy

United States
CellSight Technologies, Inc.
UCSF Imaging Center at China Basin

Recruiting

[18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation Therapy

Cancer

United States
University of Southern California
Avid Radiopharmaceuticals; Alzheimer's Therapeutic Research Institute; Alzheimer...

Completed

18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study (LEARN-Tau)

Cognition Disorders

United States
Blue Earth Diagnostics
Precision For Medicine

Completed

Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE) (PURSUE)

Brain Metastases

United States

Search clinical trials for: [18F]MNI-958

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations